UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:August 30,
Eloxx Pharmaceuticals (NASDAQ:ELOX)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Eloxx Pharmaceuticals Charts.
Eloxx Pharmaceuticals (NASDAQ:ELOX)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Eloxx Pharmaceuticals Charts.

Eloxx Pharmaceuticals, Inc. News

Eloxx Pharmaceuticals Provides Pipeline and Financing Updates
Thursday 11 July 2024 (2 weeks ago) • GlobeNewswire Inc.
Eloxx Pharmaceuticals Provides ELX-02 and ZKN-013 Program Updates
Tuesday 16 April 2024 (3 months ago) • GlobeNewswire Inc.
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Monday 1 April 2024 (4 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Friday 29 March 2024 (4 months ago) • Edgar (US Regulatory)
Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Thursday 21 March 2024 (4 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Thursday 14 March 2024 (4 months ago) • Edgar (US Regulatory)
Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to license ZKN-013 for rare dermatological diseases
Wednesday 13 March 2024 (4 months ago) • GlobeNewswire Inc.
Form 4 - Statement of changes in beneficial ownership of securities
Friday 26 January 2024 (6 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Friday 26 January 2024 (6 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Friday 26 January 2024 (6 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Friday 26 January 2024 (6 months ago) • Edgar (US Regulatory)
Form S-3 - Registration statement under Securities Act of 1933
Wednesday 24 January 2024 (6 months ago) • Edgar (US Regulatory)

More Eloxx Pharmaceuticals, Inc. News Articles